| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 16 | 2020 | 316 | 3.030 |
Why?
|
| Mycobacterium | 25 | 2019 | 249 | 1.940 |
Why?
|
| Leprosy | 11 | 2014 | 124 | 1.420 |
Why?
|
| Antigens, Bacterial | 18 | 2014 | 1171 | 1.300 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5524 | 1.130 |
Why?
|
| Mycobacterium leprae | 13 | 2014 | 94 | 1.080 |
Why?
|
| Skin Tests | 3 | 2014 | 613 | 0.910 |
Why?
|
| Lipopolysaccharides | 22 | 2018 | 2216 | 0.860 |
Why?
|
| Mycobacterium tuberculosis | 29 | 2012 | 1832 | 0.860 |
Why?
|
| Cross Infection | 7 | 2015 | 1416 | 0.860 |
Why?
|
| Glycolipids | 11 | 2020 | 204 | 0.830 |
Why?
|
| Galactans | 10 | 2002 | 31 | 0.820 |
Why?
|
| Antigens, CD1d | 4 | 2020 | 220 | 0.750 |
Why?
|
| Food Hypersensitivity | 3 | 2022 | 622 | 0.730 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 337 | 0.700 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 283 | 0.690 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2017 | 805 | 0.680 |
Why?
|
| Galactosylceramides | 2 | 2017 | 92 | 0.680 |
Why?
|
| Mycolic Acids | 12 | 2004 | 54 | 0.640 |
Why?
|
| Caffeine | 1 | 2022 | 699 | 0.630 |
Why?
|
| Mycobacterium smegmatis | 10 | 2006 | 122 | 0.600 |
Why?
|
| Hypersensitivity | 2 | 2022 | 1102 | 0.550 |
Why?
|
| Antigen Presentation | 6 | 2016 | 1284 | 0.540 |
Why?
|
| Glucosylceramides | 1 | 2014 | 28 | 0.500 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2016 | 2540 | 0.490 |
Why?
|
| Neglected Diseases | 1 | 2014 | 64 | 0.470 |
Why?
|
| Cell Wall | 16 | 2006 | 422 | 0.450 |
Why?
|
| Trehalose | 6 | 2019 | 88 | 0.440 |
Why?
|
| Drug Hypersensitivity | 4 | 2020 | 884 | 0.440 |
Why?
|
| Phenylthiourea | 2 | 2003 | 11 | 0.420 |
Why?
|
| Antitubercular Agents | 8 | 2003 | 1320 | 0.410 |
Why?
|
| Bacterial Infections | 2 | 2011 | 1401 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2019 | 1838 | 0.400 |
Why?
|
| Glycosphingolipids | 1 | 2011 | 79 | 0.390 |
Why?
|
| Vaccination | 3 | 2023 | 3278 | 0.390 |
Why?
|
| Desensitization, Immunologic | 3 | 2020 | 483 | 0.380 |
Why?
|
| Lymphocytes | 1 | 2019 | 2617 | 0.380 |
Why?
|
| Chromatography, Thin Layer | 12 | 2014 | 223 | 0.360 |
Why?
|
| Infection Control | 4 | 2011 | 966 | 0.350 |
Why?
|
| Equipment Contamination | 1 | 2011 | 185 | 0.350 |
Why?
|
| Sphingolipids | 2 | 2022 | 159 | 0.350 |
Why?
|
| Enterococcus | 3 | 1999 | 157 | 0.340 |
Why?
|
| Bacteremia | 3 | 2011 | 962 | 0.330 |
Why?
|
| Philadelphia | 5 | 2022 | 266 | 0.320 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 10 | 2002 | 31 | 0.310 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 252 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.310 |
Why?
|
| Carbohydrate Sequence | 13 | 2007 | 414 | 0.300 |
Why?
|
| Catheters | 1 | 2011 | 425 | 0.300 |
Why?
|
| Gram-Positive Bacterial Infections | 3 | 1999 | 341 | 0.300 |
Why?
|
| Cell Proliferation | 7 | 2024 | 10481 | 0.300 |
Why?
|
| Autoantigens | 1 | 2011 | 892 | 0.300 |
Why?
|
| Immunologic Memory | 2 | 2013 | 1348 | 0.290 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 7722 | 0.290 |
Why?
|
| Immune Tolerance | 3 | 2005 | 2258 | 0.290 |
Why?
|
| Vancomycin | 3 | 1999 | 501 | 0.290 |
Why?
|
| Immunity, Innate | 3 | 2019 | 2958 | 0.270 |
Why?
|
| Neuraminidase | 1 | 2005 | 210 | 0.260 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 681 | 0.260 |
Why?
|
| Carbohydrate Conformation | 10 | 1997 | 208 | 0.260 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 7 | 2018 | 361 | 0.250 |
Why?
|
| Molecular Sequence Data | 31 | 2007 | 18111 | 0.250 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 567 | 0.250 |
Why?
|
| Cell Degranulation | 2 | 2022 | 287 | 0.250 |
Why?
|
| Patient Care | 1 | 2010 | 640 | 0.240 |
Why?
|
| Safety Management | 1 | 2010 | 783 | 0.240 |
Why?
|
| Polysaccharides, Bacterial | 3 | 1997 | 578 | 0.240 |
Why?
|
| Phosphatidylinositols | 4 | 2002 | 291 | 0.240 |
Why?
|
| Vaccines | 2 | 2023 | 822 | 0.240 |
Why?
|
| Ethambutol | 4 | 1997 | 60 | 0.240 |
Why?
|
| Health Facilities | 1 | 2009 | 573 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2019 | 4479 | 0.240 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 491 | 0.230 |
Why?
|
| Antigens, CD1 | 5 | 2012 | 437 | 0.230 |
Why?
|
| Cyclins | 1 | 2006 | 603 | 0.230 |
Why?
|
| Fatty Acid Desaturases | 1 | 2003 | 102 | 0.230 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 514 | 0.230 |
Why?
|
| Clonal Anergy | 2 | 2003 | 169 | 0.220 |
Why?
|
| T-Lymphocytes | 9 | 2013 | 10180 | 0.220 |
Why?
|
| Milk | 2 | 2017 | 450 | 0.220 |
Why?
|
| Linoleic Acid | 1 | 2024 | 157 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2014 | 4386 | 0.220 |
Why?
|
| Hospitals | 2 | 2021 | 3952 | 0.220 |
Why?
|
| Drug Resistance, Microbial | 6 | 1999 | 862 | 0.220 |
Why?
|
| Tuberculosis | 8 | 2012 | 1912 | 0.210 |
Why?
|
| Bacillaceae Infections | 1 | 2011 | 8 | 0.210 |
Why?
|
| Receptors, Neuropeptide | 1 | 2022 | 111 | 0.210 |
Why?
|
| Animals | 43 | 2024 | 168757 | 0.210 |
Why?
|
| Bacillus cereus | 1 | 2011 | 35 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 5 | 2018 | 9274 | 0.200 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 379 | 0.200 |
Why?
|
| Mice | 32 | 2024 | 81183 | 0.200 |
Why?
|
| Intramolecular Transferases | 1 | 2000 | 15 | 0.190 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 36 | 0.190 |
Why?
|
| Receptors, Death Domain | 1 | 2020 | 32 | 0.190 |
Why?
|
| Allergens | 3 | 2022 | 1320 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 7 | 2011 | 7181 | 0.180 |
Why?
|
| Humans | 78 | 2023 | 744343 | 0.180 |
Why?
|
| Bacterial Proteins | 12 | 2006 | 3848 | 0.180 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2018 | 810 | 0.180 |
Why?
|
| Glycopeptides | 3 | 2000 | 224 | 0.170 |
Why?
|
| Thiourea | 1 | 1999 | 63 | 0.170 |
Why?
|
| Blood | 1 | 2011 | 598 | 0.170 |
Why?
|
| Chloramphenicol | 1 | 1998 | 75 | 0.170 |
Why?
|
| Isoniazid | 2 | 1999 | 274 | 0.170 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 407 | 0.160 |
Why?
|
| Pentosyltransferases | 5 | 1998 | 65 | 0.160 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2019 | 153 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2017 | 276 | 0.160 |
Why?
|
| Leukotrienes | 1 | 2019 | 255 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 970 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2017 | 504 | 0.160 |
Why?
|
| Mycobacteriophages | 2 | 1996 | 19 | 0.160 |
Why?
|
| Milk, Human | 1 | 2022 | 490 | 0.160 |
Why?
|
| Interferon-gamma | 9 | 2012 | 3206 | 0.160 |
Why?
|
| Basophils | 1 | 2020 | 389 | 0.160 |
Why?
|
| Medicare | 2 | 2017 | 6566 | 0.150 |
Why?
|
| Virulence Factors | 1 | 2011 | 509 | 0.150 |
Why?
|
| Biological Assay | 2 | 2019 | 652 | 0.150 |
Why?
|
| Mannose | 3 | 2012 | 124 | 0.150 |
Why?
|
| Skin Diseases, Bacterial | 2 | 1995 | 66 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2006 | 2839 | 0.150 |
Why?
|
| Salmonella typhi | 1 | 2019 | 201 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 711 | 0.150 |
Why?
|
| Mannosyltransferases | 3 | 2002 | 23 | 0.150 |
Why?
|
| Lymphedema | 1 | 2023 | 534 | 0.140 |
Why?
|
| Cloning, Molecular | 8 | 2003 | 4320 | 0.140 |
Why?
|
| Hospitalization | 2 | 2021 | 10262 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 12072 | 0.140 |
Why?
|
| Macrophages | 7 | 2024 | 5655 | 0.140 |
Why?
|
| Oligosaccharides | 3 | 1996 | 414 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5867 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2017 | 1369 | 0.140 |
Why?
|
| Phospholipids | 2 | 2019 | 784 | 0.140 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2715 | 0.130 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 1995 | 28 | 0.130 |
Why?
|
| Sugar Alcohols | 1 | 1995 | 18 | 0.130 |
Why?
|
| Glycolates | 1 | 1995 | 40 | 0.130 |
Why?
|
| Mast Cells | 1 | 2022 | 1544 | 0.130 |
Why?
|
| Amoeba | 1 | 2014 | 21 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1222 | 0.130 |
Why?
|
| Amino Acid Sequence | 16 | 2006 | 13815 | 0.130 |
Why?
|
| Cell Differentiation | 5 | 2017 | 11483 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4371 | 0.130 |
Why?
|
| Armadillos | 1 | 2014 | 7 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 1997 | 3760 | 0.130 |
Why?
|
| Cattle Diseases | 1 | 1994 | 53 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 3870 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2019 | 1836 | 0.120 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2725 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4665 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 972 | 0.120 |
Why?
|
| Cell Membrane | 6 | 2019 | 3748 | 0.120 |
Why?
|
| Signal Transduction | 7 | 2020 | 23403 | 0.120 |
Why?
|
| Leprosy, Lepromatous | 2 | 2011 | 23 | 0.120 |
Why?
|
| Metabolomics | 1 | 2022 | 1484 | 0.120 |
Why?
|
| Cell Line | 9 | 2014 | 15997 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1880 | 0.120 |
Why?
|
| Drug Stability | 1 | 2014 | 291 | 0.120 |
Why?
|
| Glucosylceramidase | 1 | 2014 | 124 | 0.120 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 588 | 0.120 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 249 | 0.120 |
Why?
|
| Hospital Administration | 2 | 2010 | 353 | 0.120 |
Why?
|
| Globosides | 1 | 2013 | 13 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2014 | 5974 | 0.110 |
Why?
|
| Guinea Pigs | 2 | 2014 | 1386 | 0.110 |
Why?
|
| Fatty Acids | 6 | 2004 | 1809 | 0.110 |
Why?
|
| Trihexosylceramides | 1 | 2013 | 32 | 0.110 |
Why?
|
| Mycobacterium avium | 2 | 2007 | 28 | 0.110 |
Why?
|
| Health Planning | 1 | 1995 | 238 | 0.110 |
Why?
|
| Receptor, erbB-2 | 2 | 2000 | 2416 | 0.110 |
Why?
|
| Molecular Structure | 6 | 2000 | 1899 | 0.110 |
Why?
|
| Female | 27 | 2023 | 380194 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 277 | 0.110 |
Why?
|
| Mass Spectrometry | 5 | 2014 | 2203 | 0.110 |
Why?
|
| Social Class | 1 | 2021 | 1999 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Drugs, Investigational | 1 | 2014 | 214 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2133 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2461 | 0.100 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 738 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 1827 | 0.100 |
Why?
|
| Cattle | 2 | 2014 | 3922 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 21827 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2007 | 1475 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1991 | 156 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 1991 | 178 | 0.100 |
Why?
|
| Lymphoma, T-Cell | 1 | 2014 | 299 | 0.100 |
Why?
|
| Male | 26 | 2023 | 350118 | 0.100 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2013 | 906 | 0.090 |
Why?
|
| Ethionamide | 2 | 2000 | 11 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 214 | 0.090 |
Why?
|
| Antigens, CD | 4 | 2013 | 4026 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 455 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1995 | 639 | 0.090 |
Why?
|
| Borderline Personality Disorder | 1 | 2017 | 736 | 0.090 |
Why?
|
| Information Management | 1 | 2010 | 101 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2327 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1917 | 0.090 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 547 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4462 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2014 | 14557 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2014 | 2019 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 1991 | 517 | 0.090 |
Why?
|
| Galactosyltransferases | 2 | 2001 | 263 | 0.090 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 2 | 2019 | 34 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2291 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 546 | 0.090 |
Why?
|
| Mannans | 2 | 2007 | 63 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 2009 | 145 | 0.080 |
Why?
|
| Patient Isolation | 1 | 2009 | 100 | 0.080 |
Why?
|
| Interleukin-2 | 4 | 2014 | 1904 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6386 | 0.080 |
Why?
|
| Hospital Costs | 1 | 1995 | 985 | 0.080 |
Why?
|
| Program Development | 1 | 2015 | 1316 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1012 | 0.080 |
Why?
|
| Mycobacterium bovis | 3 | 2003 | 150 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 1991 | 927 | 0.080 |
Why?
|
| Cell-Free System | 3 | 2003 | 344 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4468 | 0.080 |
Why?
|
| Species Specificity | 3 | 2013 | 2478 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1995 | 1821 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2018 | 1095 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 306 | 0.080 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 464 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2012 | 1267 | 0.080 |
Why?
|
| Receptors, Fc | 1 | 1991 | 541 | 0.080 |
Why?
|
| Acyltransferases | 2 | 2001 | 294 | 0.080 |
Why?
|
| DNA, Bacterial | 5 | 2009 | 1465 | 0.080 |
Why?
|
| Immune System | 1 | 2013 | 805 | 0.080 |
Why?
|
| Adult | 19 | 2021 | 214055 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 905 | 0.070 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2011 | 274 | 0.070 |
Why?
|
| Carbon Radioisotopes | 3 | 1998 | 577 | 0.070 |
Why?
|
| Middle Aged | 17 | 2021 | 213383 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 5179 | 0.070 |
Why?
|
| Lectins | 2 | 2006 | 513 | 0.070 |
Why?
|
| Models, Chemical | 3 | 2007 | 626 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2010 | 607 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 2020 | 19229 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2024 | 1147 | 0.070 |
Why?
|
| Peptidoglycan | 3 | 2007 | 246 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2022 | 41006 | 0.070 |
Why?
|
| Celiac Disease | 1 | 2014 | 785 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2007 | 547 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 119 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2014 | 6544 | 0.070 |
Why?
|
| Polysaccharides | 3 | 1997 | 1053 | 0.070 |
Why?
|
| Cyclin D2 | 1 | 2006 | 101 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 214 | 0.070 |
Why?
|
| Chromatography, Gas | 2 | 2003 | 156 | 0.070 |
Why?
|
| Pennsylvania | 3 | 2015 | 613 | 0.070 |
Why?
|
| Infant | 3 | 2022 | 35136 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.070 |
Why?
|
| Immunologic Tests | 1 | 2006 | 103 | 0.070 |
Why?
|
| Proteolipids | 1 | 2005 | 117 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2010 | 775 | 0.070 |
Why?
|
| Acylation | 3 | 1994 | 107 | 0.070 |
Why?
|
| Cell Communication | 1 | 2013 | 1621 | 0.070 |
Why?
|
| Safety | 1 | 2010 | 1186 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2006 | 256 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1877 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 354 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2006 | 316 | 0.060 |
Why?
|
| Guanosine Diphosphate Mannose | 3 | 2002 | 4 | 0.060 |
Why?
|
| Hospitals, University | 2 | 1999 | 571 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 448 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1681 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 457 | 0.060 |
Why?
|
| Disease Notification | 1 | 2005 | 97 | 0.060 |
Why?
|
| Metabolome | 1 | 2011 | 895 | 0.060 |
Why?
|
| Mannosides | 2 | 2001 | 7 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 788 | 0.060 |
Why?
|
| Leukocytes | 1 | 2013 | 2043 | 0.060 |
Why?
|
| Cell Transformation, Viral | 1 | 2006 | 565 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 226 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2006 | 367 | 0.060 |
Why?
|
| Valerates | 1 | 2004 | 21 | 0.060 |
Why?
|
| Genes, Bacterial | 2 | 1999 | 1079 | 0.060 |
Why?
|
| Professional Competence | 1 | 2007 | 447 | 0.060 |
Why?
|
| Computational Biology | 2 | 2014 | 3521 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2005 | 121 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9734 | 0.060 |
Why?
|
| Immunoglobulin E | 2 | 2020 | 1463 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 100 | 0.060 |
Why?
|
| Stearic Acids | 1 | 2003 | 53 | 0.060 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 323 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2011 | 1349 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2003 | 85 | 0.060 |
Why?
|
| Chromatography, Gel | 3 | 2002 | 668 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2000 | 1189 | 0.060 |
Why?
|
| Actins | 1 | 1991 | 2121 | 0.060 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2003 | 86 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2453 | 0.060 |
Why?
|
| Physicians | 1 | 2021 | 4567 | 0.060 |
Why?
|
| Langerhans Cells | 1 | 2004 | 173 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 372 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3843 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2004 | 143 | 0.060 |
Why?
|
| Leadership | 2 | 2015 | 1357 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1801 | 0.060 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3798 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 9438 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 8436 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3279 | 0.050 |
Why?
|
| Neutrophils | 2 | 2014 | 3719 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 2988 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2004 | 416 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2022 | 77449 | 0.050 |
Why?
|
| Drug Implants | 1 | 2003 | 244 | 0.050 |
Why?
|
| Inflammation | 2 | 2019 | 10638 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 2133 | 0.050 |
Why?
|
| Polymers | 4 | 2002 | 1621 | 0.050 |
Why?
|
| Cross Reactions | 3 | 1993 | 841 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2011 | 143 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2002 | 113 | 0.050 |
Why?
|
| Kinetics | 3 | 2001 | 6473 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2005 | 880 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2002 | 87 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2011 | 106 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 1540 | 0.050 |
Why?
|
| Phenols | 2 | 1998 | 497 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 234 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6459 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 29144 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 916 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2007 | 880 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14722 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2001 | 1801 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 258 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2023 | 493 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 203 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.050 |
Why?
|
| Escherichia coli | 6 | 2019 | 4217 | 0.050 |
Why?
|
| Hemolysin Proteins | 1 | 2000 | 113 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 253 | 0.050 |
Why?
|
| Interleukin-10 | 2 | 2017 | 1200 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 225 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 2004 | 1663 | 0.050 |
Why?
|
| HIV Infections | 2 | 2018 | 16718 | 0.050 |
Why?
|
| Basophil Degranulation Test | 1 | 2020 | 16 | 0.050 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 20 | 0.050 |
Why?
|
| Aged | 14 | 2017 | 163280 | 0.050 |
Why?
|
| Dermatophagoides farinae | 1 | 2019 | 25 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12026 | 0.050 |
Why?
|
| alpha-Galactosidase | 1 | 2020 | 57 | 0.050 |
Why?
|
| Adolescent | 7 | 2017 | 85781 | 0.050 |
Why?
|
| Virulence | 3 | 2014 | 1333 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5027 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 1613 | 0.040 |
Why?
|
| Cell Lineage | 3 | 2013 | 2504 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2020 | 195 | 0.040 |
Why?
|
| Cytokines | 2 | 2017 | 7322 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 100 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2000 | 170 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3749 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.040 |
Why?
|
| Lipoproteins | 2 | 2007 | 878 | 0.040 |
Why?
|
| Furans | 1 | 2000 | 194 | 0.040 |
Why?
|
| United States | 6 | 2021 | 69872 | 0.040 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 1999 | 3 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4644 | 0.040 |
Why?
|
| Pyrroles | 1 | 2006 | 1146 | 0.040 |
Why?
|
| Genotype | 4 | 2017 | 12951 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 224 | 0.040 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4443 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1831 | 0.040 |
Why?
|
| Vibrio cholerae | 1 | 2005 | 806 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4560 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 7939 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 893 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1999 | 166 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2010 | 1596 | 0.040 |
Why?
|
| Child | 3 | 2022 | 77709 | 0.040 |
Why?
|
| Sugar Phosphates | 1 | 1998 | 41 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3712 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 686 | 0.040 |
Why?
|
| Prodrugs | 1 | 2000 | 268 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 1008 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2017 | 6882 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2023 | 1179 | 0.040 |
Why?
|
| Research Design | 1 | 2014 | 5987 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3920 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 648 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3846 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6622 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 972 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1997 | 70 | 0.040 |
Why?
|
| Peptides | 3 | 2006 | 4409 | 0.040 |
Why?
|
| Inositol | 1 | 1999 | 218 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5217 | 0.040 |
Why?
|
| Disaster Planning | 1 | 2004 | 549 | 0.040 |
Why?
|
| Indoles | 1 | 2006 | 1839 | 0.040 |
Why?
|
| Corynebacterium | 1 | 1997 | 47 | 0.040 |
Why?
|
| Pyruvates | 2 | 1995 | 87 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 768 | 0.040 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 1423 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2017 | 64 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 197 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 212 | 0.040 |
Why?
|
| Cytosol | 1 | 2000 | 901 | 0.040 |
Why?
|
| Lipopeptides | 1 | 1997 | 75 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2005 | 2035 | 0.040 |
Why?
|
| Pentoses | 1 | 1996 | 7 | 0.040 |
Why?
|
| Trisaccharides | 2 | 1997 | 50 | 0.040 |
Why?
|
| Young Adult | 4 | 2017 | 56430 | 0.040 |
Why?
|
| Tritium | 1 | 1997 | 745 | 0.040 |
Why?
|
| Heat-Shock Proteins | 2 | 1992 | 822 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 1999 | 579 | 0.040 |
Why?
|
| Glycosylation | 2 | 2002 | 1126 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 2029 | 0.040 |
Why?
|
| Models, Structural | 1 | 1997 | 361 | 0.040 |
Why?
|
| Sepsis | 1 | 2011 | 2593 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10943 | 0.040 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 1996 | 17 | 0.040 |
Why?
|
| Amino Acids | 2 | 2013 | 1736 | 0.040 |
Why?
|
| Mentors | 2 | 2015 | 631 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 140 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2006 | 1938 | 0.030 |
Why?
|
| Epitopes | 3 | 1993 | 2571 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2013 | 5456 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1285 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 194 | 0.030 |
Why?
|
| Lung | 3 | 2024 | 9856 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2011 | 1572 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Alkylation | 1 | 1995 | 86 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1726 | 0.030 |
Why?
|
| Deuterium | 1 | 1995 | 101 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2020 | 495 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2001 | 2499 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1708 | 0.030 |
Why?
|
| Flavonoids | 1 | 1998 | 443 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2013 | 4011 | 0.030 |
Why?
|
| Galactose | 1 | 1996 | 306 | 0.030 |
Why?
|
| Patients' Rooms | 1 | 1995 | 63 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 226 | 0.030 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 112 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 471 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5788 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2006 | 3690 | 0.030 |
Why?
|
| Phylogeny | 2 | 2019 | 2803 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 154 | 0.030 |
Why?
|
| Monocytes | 2 | 2005 | 2596 | 0.030 |
Why?
|
| Ligands | 2 | 2019 | 3282 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2023 | 40561 | 0.030 |
Why?
|
| Access to Information | 1 | 2017 | 320 | 0.030 |
Why?
|
| Mycobacterium chelonae | 1 | 1993 | 11 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 2 | 1995 | 973 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 399 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1997 | 2255 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 201 | 0.030 |
Why?
|
| Hybridomas | 2 | 1992 | 452 | 0.030 |
Why?
|
| Perforin | 1 | 2014 | 168 | 0.030 |
Why?
|
| Glycosides | 1 | 1993 | 107 | 0.030 |
Why?
|
| Antibodies, Bacterial | 3 | 2006 | 1470 | 0.030 |
Why?
|
| Clarithromycin | 1 | 1993 | 86 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3772 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1996 | 648 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 1994 | 200 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 2012 | 80 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1995 | 546 | 0.030 |
Why?
|
| Structure-Activity Relationship | 3 | 2007 | 3129 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13695 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3701 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7279 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1993 | 682 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 13881 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1999 | 2373 | 0.030 |
Why?
|
| Succinates | 1 | 2012 | 83 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 2008 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 1106 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2132 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 57776 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 471 | 0.030 |
Why?
|
| Risk Factors | 6 | 2011 | 72290 | 0.030 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2256 | 0.020 |
Why?
|
| Genome, Bacterial | 2 | 2006 | 760 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 342 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 899 | 0.020 |
Why?
|
| Immune Sera | 1 | 1991 | 641 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9386 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Purchasing, Hospital | 1 | 2010 | 17 | 0.020 |
Why?
|
| Immunization | 1 | 1995 | 1256 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 474 | 0.020 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2009 | 19 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1703 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2009 | 71 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 1194 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2866 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5535 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
| Philippines | 1 | 2009 | 86 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 1995 | 1607 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 299 | 0.020 |
Why?
|
| Autoradiography | 2 | 2002 | 745 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 23338 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3218 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 2013 | 3023 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2009 | 160 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 165 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 534 | 0.020 |
Why?
|
| Phosphates | 1 | 2012 | 786 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 480 | 0.020 |
Why?
|
| Curriculum | 2 | 2015 | 3605 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3768 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1915 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 1991 | 582 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2752 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 943 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2892 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5021 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 713 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 13033 | 0.020 |
Why?
|
| Patient Admission | 1 | 1995 | 1380 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1730 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3386 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 468 | 0.020 |
Why?
|
| Tuberculin | 1 | 2006 | 66 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1539 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 95 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12261 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2007 | 153 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 252 | 0.020 |
Why?
|
| Phenotype | 3 | 2014 | 16365 | 0.020 |
Why?
|
| Chimera | 1 | 2007 | 485 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4740 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.020 |
Why?
|
| Mycobacterium marinum | 1 | 2005 | 26 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15076 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1988 | 0.020 |
Why?
|
| Inpatients | 1 | 2017 | 2518 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1878 | 0.020 |
Why?
|
| Open Reading Frames | 2 | 2000 | 810 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2003 | 573 | 0.020 |
Why?
|
| Base Sequence | 3 | 2002 | 12797 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 4894 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21746 | 0.020 |
Why?
|
| Comorbidity | 1 | 1999 | 10388 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 2716 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5391 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 507 | 0.010 |
Why?
|
| Serologic Tests | 2 | 2000 | 374 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 2004 | 53 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1413 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17446 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1866 | 0.010 |
Why?
|
| Thiophenes | 2 | 2000 | 588 | 0.010 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 214 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9727 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3340 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 4397 | 0.010 |
Why?
|
| Spleen | 1 | 2009 | 2362 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2924 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7474 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2004 | 467 | 0.010 |
Why?
|
| Esters | 1 | 2004 | 210 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2007 | 544 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 793 | 0.010 |
Why?
|
| Serine | 2 | 1997 | 826 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 15519 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1257 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2016 | 3209 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 24260 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1202 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7659 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1678 | 0.010 |
Why?
|
| Acyl-Carrier Protein S-Malonyltransferase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
| Arginine | 1 | 2005 | 944 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40075 | 0.010 |
Why?
|
| Prevalence | 1 | 1998 | 15226 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Amoxicillin | 1 | 2002 | 170 | 0.010 |
Why?
|
| Length of Stay | 1 | 1995 | 6309 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 25625 | 0.010 |
Why?
|
| Drug Industry | 1 | 2007 | 746 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 1011 | 0.010 |
Why?
|
| Urban Population | 1 | 2009 | 2021 | 0.010 |
Why?
|
| Asthma | 1 | 2019 | 6011 | 0.010 |
Why?
|
| Epidermis | 1 | 2004 | 528 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3251 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 1007 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1119 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9648 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1995 | 3114 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1791 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 63114 | 0.010 |
Why?
|
| Biotransformation | 1 | 2000 | 168 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 15295 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 475 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2001 | 562 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2559 | 0.010 |
Why?
|
| Hexosamines | 1 | 1999 | 42 | 0.010 |
Why?
|
| Penicillins | 1 | 2002 | 380 | 0.010 |
Why?
|
| Lipids | 2 | 2005 | 3305 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2005 | 1061 | 0.010 |
Why?
|
| Genomic Library | 1 | 1999 | 193 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2759 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10397 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2513 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 337 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 452 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2007 | 1181 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 2210 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4577 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2000 | 424 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 697 | 0.010 |
Why?
|
| Cord Factors | 1 | 1997 | 6 | 0.010 |
Why?
|
| Esterification | 1 | 1997 | 36 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 655 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1990 | 5097 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3200 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2004 | 1318 | 0.010 |
Why?
|
| Base Composition | 1 | 1997 | 293 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 462 | 0.010 |
Why?
|
| Azides | 1 | 1997 | 116 | 0.010 |
Why?
|
| Disaccharides | 1 | 1997 | 171 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6756 | 0.010 |
Why?
|
| Palmitates | 1 | 1997 | 74 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1997 | 133 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1682 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1997 | 154 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 768 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2699 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1998 | 406 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1085 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 878 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1997 | 1375 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2307 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1999 | 592 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4364 | 0.010 |
Why?
|
| Biopolymers | 1 | 1996 | 189 | 0.010 |
Why?
|
| Polyisoprenyl Phosphate Monosaccharides | 1 | 1994 | 3 | 0.010 |
Why?
|
| Culture Media | 1 | 1997 | 908 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4803 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1988 | 2303 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18029 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 503 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 2206 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1999 | 914 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 2212 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 1050 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2007 | 2245 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 3229 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1997 | 954 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 537 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1997 | 748 | 0.010 |
Why?
|
| India | 1 | 2000 | 2197 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.010 |
Why?
|
| Telemedicine | 1 | 2010 | 2872 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2557 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1995 | 369 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 7913 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6314 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5892 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2634 | 0.010 |
Why?
|
| Histoplasmosis | 1 | 1990 | 66 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16689 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11366 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12245 | 0.010 |
Why?
|
| Lipid A | 1 | 1988 | 67 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 847 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1990 | 981 | 0.000 |
Why?
|
| Glioma | 1 | 2003 | 3401 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 21683 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1988 | 881 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1985 | 964 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1157 | 0.000 |
Why?
|
| Interleukin-1 | 1 | 1985 | 1263 | 0.000 |
Why?
|
| Mutation | 1 | 2001 | 29786 | 0.000 |
Why?
|